PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy
Year: 2025
Type: article
Language: en
Topic: Lung Cancer Treatments and Mutations
Authors and affiliations:
raw_author_name: Yi-Long Wu
raw_affiliation_strings: Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China. syylwu@live.cn
Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China
raw_author_name: Lin Wu
raw_affiliation_strings: The Department of Thoracic Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Hunan Cancer Hospital, Central South University, Changsha, China
raw_author_name: Nan Bi
raw_affiliation_strings: State Key Laboratory of Molecular Oncology, Department of Radiation Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
raw_author_name: Timucin Cil
raw_affiliation_strings: Medical Oncology Department, Health and Science University, Adana City Education and Research Hospital, Adana, Türkiye, Turkey
raw_author_name: Hong Ge
raw_affiliation_strings: Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
raw_author_name: Zhengfei Zhu
raw_affiliation_strings: Department of Radiation Oncology, Department of Oncology, Institute of Thoracic Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China
raw_author_name: Chih-Liang Wang
raw_affiliation_strings: Division of Pulmonary Oncology and Interventional Bronchoscopy, Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
raw_author_name: Wei Zhang
raw_affiliation_strings: Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
raw_author_name: Dongqing Lv
raw_affiliation_strings: Breath Internal Medicine, Taizhou Hospital of Zhejiang Province of Wenzhou Medical University, Linhai, China
raw_author_name: E. Mingyan
raw_affiliation_strings: Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Heilongjiang, China
raw_author_name: Jianguo Sun
raw_affiliation_strings: Cancer Institute, Second Affiliated Hospital, Army Medical University, Chongqing, China
raw_author_name: Yi Pan
raw_affiliation_strings: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China
raw_author_name: Maciej Krzakowski
raw_affiliation_strings: Department of Lung Cancer and Chest Tumours, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
raw_author_name: Mustafa Dikilitas
raw_affiliation_strings: Department of Oncology, Inonu University Turgut Ozal Medical School, Malatya, Türkiye, Turkey
raw_author_name: Mehmet Ali Nahit Sendur
raw_affiliation_strings: Department of Medical Oncology, Ankara Yıldırım Beyazıt University and Ankara Bilkent City Hospital, Ankara, Türkiye, Turkey
raw_author_name: Young-Chul Kim
raw_affiliation_strings: Departments of Pulmonology and Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Republic of Korea
raw_author_name: Yanjiao Yang
raw_affiliation_strings: Global R&D (China), AstraZeneca, Shanghai, China
raw_author_name: Rui Mao
raw_affiliation_strings: Global R&D (China), AstraZeneca, Shanghai, China
raw_author_name: Biao Zhang
raw_affiliation_strings: , Biometrics, AstraZeneca, Shanghai, China
Biometrics, AstraZeneca, Shanghai, China
raw_author_name: Luhua Wang
raw_affiliation_strings: Department of Radiation Oncology, National Cancer Center/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Shen Zhen, 518116, China. wlhwq@yahoo.com
Department of Radiation Oncology, National Cancer Center/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Shen Zhen, 518116, China